Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr. Ehud Baron

Dr. Ehud Baron

Chairman, President/CTO, X-Cardio Corp. KK Japan

Prof. Dr. Ersin Akpinar

Prof. Dr. Ersin Akpinar

Professor of Clinical Family Medicine, Cukurova University, Adana - Turkey Turkey

Prof. Remigijus Zaliunas

Prof. Remigijus Zaliunas

Lithuanian University of Health Sciences Lithuania

Dr. Yumei Ye

Dr. Yumei Ye

University of Texas Medical Branch USA

Dr. Yochai Birnbaum

Dr. Yochai Birnbaum

Baylor College of Medicine USA

Grace M. Egeland

Grace M. Egeland

University of Bergen Norway

Dr. Marcello Finardi Peixoto

Dr. Marcello Finardi Peixoto

Federal University of Sao Paulo (UNIFESP) Brazil

Ms. Rola Bou Serhal

Ms. Rola Bou Serhal

Lebanese University Lebanon

Euro Hypertension 2021

About Conference


"9th World Congress on Hypertension, Cardiology, Primary Health and Patient Care” cordially invites all participants across the globe to attend the Webinar on November  29-30, 2021. This two-day event will cover Keynote sessions of leading experts, plenary talks, and poster presentations of researchers and other academicians.

Theme: Know your numbers, Control It and Live Longer

Euro Hypertension 2021 will lay a stage for all the researchers, elite professors, and cardiologists, nephrologists, endocrinologists, therapists, osteopathicians, bariatric, attendants, medical services experts to talk about a methodology for hypertension and finding, therapy and prevention of elevated blood pressure.

Hypertension is fairly common among the human population and is often unregulated; however, an uncontrolled increase in blood pressure leaves the individuals at risk to develop heart ailments. According to a report by the World Health Organization in 2018, 1.1 billion people in the world have raised blood pressure and less than 1 in 5 have it under control. Treatment of cardiovascular infection frequently requires the administration of various drugs for extensive stretches of time to patients prone to be old and experiencing a scope of co-dismal conditions. This Conference is dedicated to inciting discussions that promote innovations and fresh perspectives to the existing research related to cardiovascular diseases and hypertension.

Why To Attend ?

Hypertension 2021 is a distinctive forum to assemble worldwide distinguished academics within the field of cardiology, nephropathy, neuropathy, endocrinology, psychiatry , public health professionals, scientists, educational scientists, industry researchers, scholars to exchange concerning state of the art analysis and provides the best chance to reach the biggest gathering of participants from round the world. Conduct displays, distribute and update information concerning the current state of affairs of hypertension treatment and their effects that leads to the downfall of the society. This 2-day event can surely profit and paves the way for the betterment of the globe. Broadly acclaimed speakers, the foremost recent researches and updates in hypertension are the key features of this event.

The benefits provided to the attendees are:

  • CME accreditation certificates will be provided to all speakers, delegates and students
  • Opportunity to meet the world’s renowned speakers at this event
  • Keynote forums by Prominent Physicians & Professors
  • Oral/Poster presentations by Young Researchers
  • Best poster award for students

Why Webinar?

This is how webinars have become the new normal. They are an extraordinary method to deal with your professional activities while keeping up social distancing. Although webinars are not a new discovery, there is a definite increase in their use and we see more and more conferences opting for this method to reach out to their participants.

In fact, according to a study conducted by GoToWebinars in 2019 (months before the coronavirus outbreak), a massive 73 percent had already started the use of webinars. Additionally, 57 percent of them have decided to continue creating more webinars in order to generate awareness. Fast forward to March 2020, the number of such online events hosted has increased by 330 percent, and the numbers of attendees are doubling with each passing month.

Market Analysis

As per a statement of the World Health Organization (WHO), Hypertension is one of the silent killers in the 21st century and is one of the biggest global public health concerns. Hypertension is a major contributor to cardiac complications, stroke, heart diseases, kidney failure, blindness, including premature death and disabilities. Hypertension is curable as well as treatable for which there is a need for involvement from individual entities, government and private sectors, health workers, civil societies, and moreover individual awareness is highly recommended.

As per the estimation of WHO, globally more than 1.13 billion people are affected with Hypertension among which less than 1 in each 5 is under control. Unfortunate eating regimens, absence of physical exercises, utilization of liquor, and tobacco are the fundamental contributing elements of Hypertension. To lessen the predominance by 25% by 2025, WHO alongside the United States Center for Disease Control and Prevention dispatched the Global heart Initiative in 2016. Globally, Hypertension or High Blood Pressure leads to 7.5million death cases which share about 12.8% of all death cases recorded. Hypertension is also accounted for about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & hemorrhagic stroke.

The global prevalence of Hypertension in adults aged>25 was about 40% in 2008. Between 1980 to 2008 the prevalence was moderate. But, due to the sharp growth in population, the aging population the uncontrolled Hypertension reached 1 billion in 2008 from 600 million. The prevalence of hypertension was highest in Africa (>40%) and lower in the Americas (35%).

As per the research of some independent firms, the global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. The main Drugs in the Hypertension market are Tacleer, Uptravi, Opsumit, Letairis, Adcirca, Revatio, Adempas, Veletri, Oremitram, Tyvaso, Remodulin. Major classes of drugs used are Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin-Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors. Major players in the antihypertensive drugs market are: Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Sanofi Aventis, and United Therapeutics.

Past Conference Report

Hypertension 2020

Euro Hypertension 2020 Organizing Committee would like to thank each and every participant of Euro Hypertension 2020 webinar to make this a huge success. And special thanks to media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by:

  • Dr. Naveed Shaikh, MBBS, FCPS, NICVD Pakistan
  • Professor Fatih Yalcin, MD, FESC, Mustafa Kemal University Medical School, Antioch, TR
  • Dr. Ananda G.C., Chitwan Medical College, Bharatpur, Chitwan, Nepal
  • P.Y. Pramana, Faculty of Medicine and Health Science, Warmadewa University, Bali, Indonesia.
  • Daniel Haruna, Faculty of Clinical Sciences, College of Health Sciences, University Of Abuja, Behind University of Abuja Teaching hospital, PMB 117, Gwagwalada
  • Resti Tito Villarino, Cebu Technological University, Moalboal, Cebu, Philippines
  • Sara Abouradi, CHU IBN ROCHD , Casablanca, Morocco

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums at Hypertension 2020. We sincerely thank the Organizing Committee Members, Editorial Board Members of International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, we would like to announce the commencement of the "9th World Congress on Hypertension, Cardiology, Primary Health and Patient Care", October 25-26, 2021 Webinar

 Let us meet again @ Euro Hypertension 2021, October 25-26, 2021 | Webinar


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 29-30, 2021

For Sponsors & Exhibitors

s[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Hypertension: Open Access Interventional Cardiology Journal Journal of Patient Care

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by